Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CAPSTONE-HOLDING-CORP-111313474/news/Capstone-Therapeutics-Announces-Initiation-of-Dosing-for-AEM-28-Phase-1b-2a-Human-Clinical-Trial-in-38692809/?utm_source=whatsapp&utm_medium=social&utm_campaign=share